With ~ 70% people living with diabetes also suffering from weight issues 1 , “Diabesity” has become a major global health challenge. Management of diabesity requires a holistic, multifactorial, person-centric approach. While traditional antidiabetic therapies may worsen weight gain, early and targeted management of weight through pharmacologic options, in adjunct to diet and exercise, is essential to prevent disease progression.
Semaglutide 1.0 mg, a global blockbuster and the #1 prescribed GLP-RA in the world 2 , has shown strong evidence in providing powerful glycaemic control 3 and compelling weight loss 4 . It has been extensively studied in the SUSTAIN programme for efficacy and safety, positioning it as a valuable therapy in the management of diabesity in India. Join us for an impactful clinical webinar on 10th December 2025 from 8.00 PM to 8.45 PM , where leading experts will…
